Anogen Life Sciences Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Anogen Life Sciences General Information

Description

Developer of a sustained release drug delivery system designed to offer the local delivery of biologic and small molecule drugs. The company's system is designed to significantly enhance and improve the therapeutic characteristics of new and approved drugs, enabling medical practitioners to improve vision and prevent blindness with the use of these therapeutic systems.

Contact Information

Website
www.therakine.com
Formerly Known As
Therakine
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 7901 4th Street North
  • Suite 300
  • St. Petersburg, FL 33702
  • United States
+1 (404)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 7901 4th Street North
  • Suite 300
  • St. Petersburg, FL 33702
  • United States
+1 (404)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anogen Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 27-Dec-2021 Completed Out of Business
2. Later Stage VC 05-Feb-2021 Completed Generating Revenue
1. Later Stage VC 01-Sep-2020 Completed Generating Revenue
To view Anogen Life Sciences’s complete valuation and funding history, request access »

Anogen Life Sciences Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Anogen Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100028328-A1 Topical treatment for diseases of eye surface Inactive 12-Jun-2006
EP-2026822-A1 Topical treatment for diseases of eye surface Inactive 12-Jun-2006
JP-2009539977-A Topical treatment of ocular surface disease Pending 12-Jun-2006
CA-2654565-A1 Topical treatment for diseases of eye surface Inactive 12-Jun-2006
EP-2026822-A4 Topical treatment for diseases of eye surface Inactive 12-Jun-2006 A61K45/06
To view Anogen Life Sciences’s complete patent history, request access »

Anogen Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Anogen Life Sciences FAQs

  • When was Anogen Life Sciences founded?

    Anogen Life Sciences was founded in 2006.

  • Where is Anogen Life Sciences headquartered?

    Anogen Life Sciences is headquartered in St. Petersburg, FL.

  • What is the size of Anogen Life Sciences?

    Anogen Life Sciences has 4 total employees.

  • What industry is Anogen Life Sciences in?

    Anogen Life Sciences’s primary industry is Drug Delivery.

  • Is Anogen Life Sciences a private or public company?

    Anogen Life Sciences is a Private company.

  • What is Anogen Life Sciences’s current revenue?

    The current revenue for Anogen Life Sciences is .

  • How much funding has Anogen Life Sciences raised over time?

    Anogen Life Sciences has raised $408K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »